MARKET

EXAS

EXAS

Exact Sciences Corp
NASDAQ
68.07
+1.81
+2.72%
Opening 12:10 03/31 EDT
OPEN
66.51
PREV CLOSE
66.26
HIGH
68.14
LOW
65.81
VOLUME
1.10M
TURNOVER
55.56M
52 WEEK HIGH
76.94
52 WEEK LOW
29.27
MARKET CAP
12.13B
P/E (TTM)
-19.2345
1D
5D
1M
3M
1Y
5Y
Exact Sciences (EXAS) Stock Sinks As Market Gains: What You Should Know
NASDAQ · 18h ago
Emergent Biosolutions (EBS) Down 28.1% Since Last Earnings Report: Can It Rebound?
NASDAQ · 2d ago
Invesco FTSE RAFI US 1500 Small-Mid ETF Experiences Big Outflow
NASDAQ · 2d ago
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
NASDAQ · 4d ago
Exact Sciences (EXAS) Outpaces Stock Market Gains: What You Should Know
NASDAQ · 03/23 22:15
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
NASDAQ · 03/23 10:20
BRIEF-Exact Sciences Corp Files Prospectus For Resale Of Up To 5.2 Million Shares Of Common Stock By Selling Stockholders - SEC Filing
Reuters · 03/17 20:19
If You Invested $10,000 in Exact Sciences in 2018, This Is How Much You Would Have Today
NASDAQ · 03/16 14:07
More
About EXAS
Exact Sciences Corporation is a global advanced cancer diagnostics company. The Company provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. The Company is focusing its research and development efforts on three main areas: Colorectal Cancer Screening, MCED Test Development and MRD Test Development. The Company’s products include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, OncoExTra Test and COVID-19 Testing. Its flagship screening product, the Cologuard test, is a non-invasive, stool-based deoxyribonucleic acid (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patient’s breast tumor tissue.

Webull offers kinds of Exact Sciences Corp stock information, including NASDAQ:EXAS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EXAS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading EXAS stock methods without spending real money on the virtual paper trading platform.